Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2023-504915-34-00Phase 2Authorised
Phase 2 trial of dobutamine in Hemodynamic insufficiency (HI), sponsored by Hospital Universitario La Paz. Planned start Jun 2023; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2023-504915-34-00.